1 |
[otl-200] |
- |
- |
- |
- |
019 [1] 19 💬 |
2 |
Abatacept (aba) + methotrexate (mtx), double-blind (db) |
Abatacept |
[3] D00142 D00142, D02115 D02115, D03203 D03203 💬 |
CD80 [4] CD80, CD86, DHFR, DHFR2 💬 |
Allograft rejection [17] Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
046 [1] 46 💬 |
3 |
Abatacept + methotrexate |
Abatacept |
[3] D00142 D00142, D02115 D02115, D03203 D03203 💬 |
CD80 [4] CD80, CD86, DHFR, DHFR2 💬 |
Allograft rejection [17] Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
046 [1] 46 💬 |
4 |
Adalimumab 40 mg sc every other week |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
271 [1] 271 💬 |
5 |
Adalimumab 40 mg subcutaneous (sc) every other week (eow) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
6 |
Adalimumab with methotrexate |
Adalimumab |
[3] D00142 D00142, D02115 D02115, D02597 D02597 💬 |
DHFR [3] DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
7 |
Any other approved antiepileptic drug |
- |
- |
- |
- |
144 [1] 144 💬 |
8 |
Apply veregen ® 10 % on a randomized area and the moisturizing cream of the other side |
- |
- |
- |
- |
160 [1] 160 💬 |
9 |
Apremilast |
Apremilast |
[1] D08860 D08860 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 [6] 46, 50, 56, 97, 162, 271 💬 |
10 |
Apremilast (cc-10004) |
Apremilast |
[1] D08860 D08860 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
056 [1] 56 💬 |
11 |
Apremilast 20 mg |
Apremilast |
[1] D08860 D08860 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 [1] 46 💬 |
12 |
Apremilast 30 mg |
Apremilast |
[1] D08860 D08860 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 [1] 46 💬 |
13 |
Apremilast 30mg |
Apremilast |
[1] D08860 D08860 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
050 [1] 50 💬 |
14 |
Apremilast tablet 20 mg |
Apremilast |
[1] D08860 D08860 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
271 [1] 271 💬 |
15 |
Apremilast tablet 30 mg bid |
Apremilast |
[1] D08860 D08860 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
271 [1] 271 💬 |
16 |
Azathioprine or methotrexate |
Azathioprine |
[4] D00142 D00142, D00238 D00238, D02115 D02115, D03033 D03033 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 [1] 96 💬 |
17 |
Behavioral: other academic sham tutoring |
- |
- |
- |
- |
034 [1] 34 💬 |
18 |
Bmn 110 - every other week |
- |
- |
- |
- |
019 [1] 19 💬 |
19 |
Bmn 110 every other week |
- |
- |
- |
- |
019 [1] 19 💬 |
20 |
Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) |
Digoxin |
[13] D00298 D00298, D00330 D00330, D00455 D00455, D00529 D00529, D00550 D00550, D00696 D00696, D01207 D01207, D01475 D01475, D02290 D02290, D05028 D05028, D05259 D05259, D05261 D05261, D08229 D08229 💬 |
ATP1A1 [25] ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 |
Adrenergic signaling in cardiomyocytes [49] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
21 |
Bms-582949 and methotrexate |
BMS-582949 |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
22 |
Bromocriptine and other dopamine agonists |
Bromocriptine |
[4] D00633 D00633, D00780 D00780, D03165 D03165, D07870 D07870 💬 |
DRD1 [6] DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬 |
Alcoholism [15] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
23 |
Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf |
Busulfan |
[8] D00107 D00107, D00142 D00142, D00248 D00248, D01907 D01907, D02115 D02115, D03235 D03235, D07966 D07966, D08556 D08556 💬 |
CSF3R [9] CSF3R, DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 |
Alzheimer disease [46] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
24 |
Certolizumab pegol + methotrexate (mtx) |
Certolizumab pegol |
[3] D00142 D00142, D02115 D02115, D03441 D03441 💬 |
DHFR [3] DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
25 |
Cipro (ciprofloxacin, bayq3939) |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
26 |
Ciprofloxacin |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
002 [5] 2 , 60, 96, 97, 299 💬 |
27 |
Ciprofloxacin (bayq3939) dry powder for inhalation |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
28 |
Ciprofloxacin (cipro inhale, bayq3939) |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
29 |
Ciprofloxacin (cipro, bayq3939) |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
30 |
Ciprofloxacin (ciproxin) |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
31 |
Ciprofloxacin dispersion for inhalation |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
32 |
Ciprofloxacin dpi |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
33 |
Ciprofloxacin dpi (bayq3939) |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
34 |
Ciprofloxacin for inhalation |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
35 |
Ciprofloxacin hydrochloride |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
096 [2] 96, 299 💬 |
36 |
Ciprofloxacin hydrochloride monohydrate |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
37 |
Ciprofloxacin inhale |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
38 |
Clartihromycin, amoxicillin, and omeprazole |
Amoxicillin |
[7] D00229 D00229, D00455 D00455, D01207 D01207, D02925 D02925, D05259 D05259, D05261 D05261, D07452 D07452 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [1] 6 💬 |
39 |
Clobetasol propionate + methotrexate |
Clobetasol |
[4] D00142 D00142, D01272 D01272, D02115 D02115, D07715 D07715 💬 |
DHFR [3] DHFR, DHFR2, NR3C1 💬 |
Antifolate resistance [6] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate |
162 [1] 162 💬 |
40 |
Combination product: methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
41 |
Cp-690,550 + methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
42 |
Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids |
Azathioprine |
[6] D00142 D00142, D00238 D00238, D00287 D00287, D02115 D02115, D03033 D03033, D07760 D07760 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
044 [1] 44 💬 |
43 |
Cyclosporin, methotrexate (gvhd prophylaxis) |
Cyclosporine |
[3] D00142 D00142, D00184 D00184, D02115 D02115 💬 |
DHFR [7] DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
326 [1] 326 💬 |
44 |
Diagnostic test: other exploratory blood biomarkers |
- |
- |
- |
- |
298 [1] 298 💬 |
45 |
Diclofenac + omeprazole |
Diclofenac |
[7] D00455 D00455, D00903 D00903, D00904 D00904, D01207 D01207, D05259 D05259, D05261 D05261, D07816 D07816 💬 |
ATP4A [4] ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
46 |
Dimebon + omeprazole |
Latrepirdine |
[5] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261, D09917 D09917 💬 |
ACHE [8] ACHE, ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [26] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
47 |
Dmards (methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
48 |
Early immunosuppressants (azathioprine, methotrexate) |
Azathioprine |
[4] D00142 D00142, D00238 D00238, D02115 D02115, D03033 D03033 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 [1] 96 💬 |
49 |
Enalapril and other angiotensin converting enzyme inhibitors |
Angiotensin II |
[4] D00150 D00150, D00621 D00621, D02014 D02014, D07892 D07892 💬 |
ACE [3] ACE, AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
019 [1] 19 💬 |
50 |
Etanercept + methotrexate |
Etanercept |
[3] D00142 D00142, D00742 D00742, D02115 D02115 💬 |
DHFR [4] DHFR, DHFR2, LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
51 |
Etanercept , methotrexate |
Etanercept |
[3] D00142 D00142, D00742 D00742, D02115 D02115 💬 |
DHFR [4] DHFR, DHFR2, LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
52 |
Etanercept, methotrexate and depomedrone |
Etanercept |
[3] D00142 D00142, D00742 D00742, D02115 D02115 💬 |
DHFR [4] DHFR, DHFR2, LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
53 |
Etanercept, methotrexate, prednisolone |
Etanercept |
[11] D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
056 [1] 56 💬 |
54 |
Etanercept, other biologics, disease-modifying antirheumatic drugs (dmards), etc |
Etanercept |
[1] D00742 D00742 💬 |
LTA [2] LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
55 |
Ethylmethylcarbamic acid 3-[(1s)-1-(dimethylamino)ethyl]phenyl ester (**see other 2 names below) |
- |
- |
- |
- |
006 [1] 6 💬 |
56 |
Ezetimibe + other lipid-lowering medication(s) |
Ezetimibe |
[1] D01966 D01966 💬 |
NPC1L1 [1] NPC1L1 💬 |
Fat digestion and absorption [1] Fat digestion and absorption |
260 [1] 260 💬 |
57 |
Fixed dose combination ciprofloxacin/celecoxib |
Celecoxib |
[3] D00186 D00186, D00567 D00567, D02216 D02216 💬 |
PTGS2 [1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 [1] 2 💬 |
58 |
Fluocinolone acetonide |
Fluocinolone |
[1] D01825 D01825 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
090 [1] 90 💬 |
59 |
Genetic: infusion of autologous cryopreserved efs-ada lv cd34+ cells (otl-101) |
- |
- |
- |
- |
065 [1] 65 💬 |
60 |
Genetic: infusion of autologous efs-ada lv cd34+ (otl-101) |
- |
- |
- |
- |
065 [1] 65 💬 |
61 |
Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate) |
Azathioprine |
[8] D00142 D00142, D00238 D00238, D00752 D00752, D02115 D02115, D03033 D03033, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
DHFR [4] DHFR, DHFR2, IMPDH1, IMPDH2 💬 |
Antifolate resistance [7] Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Purine metabolism |
049 [1] 49 💬 |
62 |
Infliximab + methotrexate (mtx) |
Infliximab |
[3] D00142 D00142, D02115 D02115, D02598 D02598 💬 |
DHFR [3] DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
63 |
Infliximab, methylprednisolone, methotrexate |
Infliximab |
[9] D00142 D00142, D00407 D00407, D00751 D00751, D00979 D00979, D02115 D02115, D02598 D02598, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
DHFR [4] DHFR, DHFR2, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
64 |
Intrathecal methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
013 [1] 13 💬 |
65 |
L01x - other antineoplastic agents |
- |
- |
- |
- |
085 [1] 85 💬 |
66 |
Losartan and other angiotensin receptor blockers |
Angiotensin II |
[4] D00150 D00150, D00357 D00357, D02014 D02014, D08146 D08146 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
019 [1] 19 💬 |
67 |
M2951 (other name: evobrutinib) |
Evobrutinib |
- |
- |
- |
049 [1] 49 💬 |
68 |
Methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 [35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
69 |
Methotrexate 'lederle' 2,5mg tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
70 |
Methotrexate 'lederle' 2.5mg tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
71 |
Methotrexate 'lederle' tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
72 |
Methotrexate (metoject® prefilled pen) |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
73 |
Methotrexate (mtx) |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
74 |
Methotrexate (stable dose) |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
75 |
Methotrexate (tapering dose) |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
76 |
Methotrexate + biologic administration |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
77 |
Methotrexate + infliximab |
Infliximab |
[3] D00142 D00142, D02115 D02115, D02598 D02598 💬 |
DHFR [3] DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
78 |
Methotrexate + methylprednisolone |
Methotrexate |
[8] D00142 D00142, D00407 D00407, D00751 D00751, D00979 D00979, D02115 D02115, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
DHFR [3] DHFR, DHFR2, NR3C1 💬 |
Antifolate resistance [6] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate |
046 [1] 46 💬 |
79 |
Methotrexate + salazopyrine + hydroxychloroquine administration |
Hydroxychloroquine |
[3] D00142 D00142, D02115 D02115, D08050 D08050 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
80 |
Methotrexate - amneal |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
81 |
Methotrexate - dava |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
82 |
Methotrexate - delay |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
83 |
Methotrexate - etanercept - prednisolone arm |
Etanercept |
[11] D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
84 |
Methotrexate - immediate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
85 |
Methotrexate 10 mg |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
86 |
Methotrexate 10 mg tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
87 |
Methotrexate 2.5 mg |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
044 [1] 44 💬 |
88 |
Methotrexate 2.5 mg tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
89 |
Methotrexate 2.5mg tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
90 |
Methotrexate 2.5mg tablets bp |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
91 |
Methotrexate 25 mg |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
044 [1] 44 💬 |
92 |
Methotrexate 50mg/ml solution for injection, pre-filled syringe |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
93 |
Methotrexate ``lederle`` 2.5mg tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
94 |
Methotrexate and folic acid |
Folic acid |
[3] D00070 D00070, D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
049 [1] 49 💬 |
95 |
Methotrexate as methotrexate disodium |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
96 |
Methotrexate bellon |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
097 [1] 97 💬 |
97 |
Methotrexate bellon 25mg/ml |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
097 [1] 97 💬 |
98 |
Methotrexate capsules |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
99 |
Methotrexate disodium |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [3] 46, 96, 97 💬 |
100 |
Methotrexate ebewe |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
101 |
Methotrexate hospira 2,5 mg tablety |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
102 |
Methotrexate hospira 2.5 mg tablety |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
103 |
Methotrexate injection |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 [2] 96, 97 💬 |
104 |
Methotrexate lachema 5inj. sol |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 [1] 50 💬 |
105 |
Methotrexate lederle 2.5 mg tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
106 |
Methotrexate pfizer 2,5 mg tabletter |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
107 |
Methotrexate placebo |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
108 |
Methotrexate plus enbrel or enbrel alone |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
109 |
Methotrexate plus erb-041 for 12 weeks |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
110 |
Methotrexate plus sulfasalazine |
Methotrexate |
[3] D00142 D00142, D00448 D00448, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
111 |
Methotrexate pre-filled pen |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
112 |
Methotrexate prefilled pen |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
113 |
Methotrexate prefilled syringe |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
114 |
Methotrexate sodium |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [2] 46, 256 💬 |
115 |
Methotrexate sodium 2.5mg tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
116 |
Methotrexate sodium tablets 2.5 mg |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
117 |
Methotrexate sodium tablets 2.5mg |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
118 |
Methotrexate tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
040 [1] 40 💬 |
119 |
Methotrexate tablets 2.5 mg |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
120 |
Methotrexate treatment |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
041 [2] 41, 46 💬 |
121 |
Methotrexate wyeth 2,5mg |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 [1] 50 💬 |
122 |
Methotrexate wyeth 2,5mg tbl. |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 [1] 50 💬 |
123 |
Methotrexate ® 2.5mg tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
124 |
Methotrexate(mtx) |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
125 |
Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
126 |
Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol. |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
127 |
Methotrexate(necessary) |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
128 |
Methotrexate*100cpr 2,5mg |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
129 |
Methotrexate*10mg/1,33ml 4s |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
130 |
Methotrexate*15mg/2ml 4sir |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
131 |
Methotrexate*2,5mg 25cpr |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
132 |
Methotrexate*20mg/2,66ml 4s |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
133 |
Methotrexate*25cpr 2,5mg |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
134 |
Methotrexate*7,5mg/ml 4sir. |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
135 |
Methotrexate, leucovorin and bms-986142 |
BMS-986142 |
[5] D00142 D00142, D01211 D01211, D02115 D02115, D07986 D07986, D07987 D07987 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
136 |
Methotrexate,adalimumab |
Adalimumab |
[3] D00142 D00142, D02115 D02115, D02597 D02597 💬 |
DHFR [3] DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
137 |
Methotrexate-lachema |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
138 |
Methotrexate-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
[4] D00142 D00142, D00448 D00448, D02115 D02115, D08050 D08050 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
139 |
Methotrexate® 2.5 mg tablets |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
140 |
Methylprednisolone (or other glucocorticoid) |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [1] 43 💬 |
141 |
Mp-435(dose1) + methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
142 |
Msdmds other than betaseron (interferon beta-1b, bay86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
143 |
Mycophenolate mofetil,methotrexate |
Methotrexate |
[6] D00142 D00142, D00752 D00752, D02115 D02115, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
DHFR [4] DHFR, DHFR2, IMPDH1, IMPDH2 💬 |
Antifolate resistance [7] Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Purine metabolism |
042 [3] 42, 43, 45 💬 |
144 |
Naproxen 500 mg tablets (pn 200 minus omeprazole) |
Naproxen |
[5] D00118 D00118, D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [4] ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [2] 46, 271 💬 |
145 |
Omeprazole |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
146 |
Omeprazole (uk licensed generic product) |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
085 [1] 85 💬 |
147 |
Omeprazole 20 mg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 [2] 96, 97 💬 |
148 |
Omeprazole 20mg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
051 [1] 51 💬 |
149 |
Omeprazole 20mg bid |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
098 [1] 98 💬 |
150 |
Omeprazole 40 mg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 [1] 96 💬 |
151 |
Omeprazole 40mg capsule |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
299 [1] 299 💬 |
152 |
Omeprazole magnesium |
Magnesium |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
225 [1] 225 💬 |
153 |
Omeprazole rectally 1mg/kg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
294 [1] 294 💬 |
154 |
Oral ciprofloxacin |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
155 |
Oral ciprofloxacin plus inhaled colistin |
Ciprofloxacin |
[4] D00186 D00186, D02138 D02138, D02216 D02216, D07746 D07746 💬 |
- |
- |
299 [1] 299 💬 |
156 |
Oral methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
157 |
Ot |
- |
- |
- |
- |
193 [1] 193 💬 |
158 |
Otelixizumab |
Otelixizumab |
[1] D08959 D08959 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
046 [1] 46 💬 |
159 |
Otezla |
- |
- |
- |
- |
056 [2] 56, 162 💬 |
160 |
Other analgesics and antipyretics |
- |
- |
- |
- |
013 [1] 13 💬 |
161 |
Other antiepileptics |
- |
- |
- |
- |
140 [1] 140 💬 |
162 |
Other biologic therapies |
- |
- |
- |
- |
096 [1] 96 💬 |
163 |
Other biological agent |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
164 |
Other biologics |
- |
- |
- |
- |
046 [1] 46 💬 |
165 |
Other cox-2 inhibitor |
- |
- |
- |
- |
271 [1] 271 💬 |
166 |
Other cox-2 inhibitors |
- |
- |
- |
- |
271 [1] 271 💬 |
167 |
Other crystalloid |
- |
- |
- |
- |
296 [1] 296 💬 |
168 |
Other disease-modifying therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
169 |
Other dmards |
- |
- |
- |
- |
046 [1] 46 💬 |
170 |
Other h1 antagonist |
- |
- |
- |
- |
013 [1] 13 💬 |
171 |
Other hematological agents |
- |
- |
- |
- |
065 [1] 65 💬 |
172 |
Other nervous system drugs |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
173 |
Other non steroidal anti-inflammatory drugs (nsaids) except etodolac |
Etodolac |
[1] D00315 D00315 💬 |
PTGS2 [1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
174 |
Other non-selective nsaids |
- |
- |
- |
- |
271 [1] 271 💬 |
175 |
Other non-sponsor pancreatic enzyme replacement therapy |
- |
- |
- |
- |
299 [1] 299 💬 |
176 |
Other parkinson's disease treatments |
- |
- |
- |
- |
006 [1] 6 💬 |
177 |
Other respiratory system products |
- |
- |
- |
- |
299 [1] 299 💬 |
178 |
Other sources |
- |
- |
- |
- |
228 [1] 228 💬 |
179 |
Other vasodilator |
- |
- |
- |
- |
051 [1] 51 💬 |
180 |
Other: |
- |
- |
- |
- |
002 [2] 2 , 65 💬 |
181 |
Other: 0 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
182 |
Other: 0.02% fm, sh, tbcl |
- |
- |
- |
- |
053 [1] 53 💬 |
183 |
Other: 0.9% sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
065 [1] 65 💬 |
184 |
Other: 0.9ml sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
271 [1] 271 💬 |
185 |
Other: 1 food elimination diet |
- |
- |
- |
- |
098 [1] 98 💬 |
186 |
Other: 1 food elimination diet therapy |
- |
- |
- |
- |
098 [1] 98 💬 |
187 |
Other: 100% pomegranate juice |
Pomegranate |
- |
- |
- |
096 [2] 96, 97 💬 |
188 |
Other: 13c6 leucine |
Leucine |
[1] D00030 D00030 💬 |
- |
- |
005 [3] 5 , 7 , 127 💬 |
189 |
Other: 18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
046 [2] 46, 84 💬 |
190 |
Other: 18f-fdg pet/ct |
Fludeoxyglucose (18F) |
- |
- |
- |
041 [1] 41 💬 |
191 |
Other: 18f-fluorodeoxyglucose (18f-fdg) pet/ct |
Fludeoxyglucose (18F) |
- |
- |
- |
084 [1] 84 💬 |
192 |
Other: 18f-ge-180 |
Flutriciclamide F-18 |
- |
- |
- |
046 [1] 46 💬 |
193 |
Other: 2h standardized aerobic exercise |
- |
- |
- |
- |
078 [1] 78 💬 |
194 |
Other: 31-phosphorus rmn spectroscopy |
Phosphorus |
- |
- |
- |
008 [1] 8 💬 |
195 |
Other: 4 food elimination diet |
- |
- |
- |
- |
098 [1] 98 💬 |
196 |
Other: 4 food elimination diet (post 1fed failure) |
- |
- |
- |
- |
098 [1] 98 💬 |
197 |
Other: 5-asa withdrawal |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
198 |
Other: 6 food elimination diet (after 1fed failure) |
- |
- |
- |
- |
098 [1] 98 💬 |
199 |
Other: 6 food elimination diet therapy |
- |
- |
- |
- |
098 [1] 98 💬 |
200 |
Other: 60% oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
201 |
Other: [11c]-methionine pet/mri |
Methionine |
[2] D00019 D00019, D04983 D04983 💬 |
- |
- |
075 [1] 75 💬 |
202 |
Other: [11c]donepezil pet |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
203 |
Other: a-step |
- |
- |
- |
- |
299 [1] 299 💬 |
204 |
Other: a-step (new protocol) |
- |
- |
- |
- |
299 [1] 299 💬 |
205 |
Other: abdominal compression |
- |
- |
- |
- |
017 [1] 17 💬 |
206 |
Other: absorptive clearance scan |
- |
- |
- |
- |
299 [1] 299 💬 |
207 |
Other: acute response to high-impact exercise |
- |
- |
- |
- |
096 [1] 96 💬 |
208 |
Other: ad libitum water intake |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
209 |
Other: adalimumab |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
210 |
Other: adalimumab treatment |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
151 [1] 151 💬 |
211 |
Other: additional therapies |
- |
- |
- |
- |
097 [1] 97 💬 |
212 |
Other: air - oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
213 |
Other: amyotrophic lateral sclerosis functional rating scale-revised |
- |
- |
- |
- |
002 [1] 2 💬 |
214 |
Other: antigen (wheat base soy sauce) spray |
Wheat |
[1] D06902 D06902 💬 |
- |
- |
098 [1] 98 💬 |
215 |
Other: anxiety |
- |
- |
- |
- |
013 [1] 13 💬 |
216 |
Other: assessment of medication compliance |
- |
- |
- |
- |
098 [1] 98 💬 |
217 |
Other: autogenic drainage |
- |
- |
- |
- |
299 [1] 299 💬 |
218 |
Other: autologous platelet rich plasma |
- |
- |
- |
- |
035 [1] 35 💬 |
219 |
Other: autologous serum and rebamipide 2% |
Rebamipide |
[1] D01121 D01121 💬 |
- |
- |
053 [1] 53 💬 |
220 |
Other: avise pg - diagnostic test |
- |
- |
- |
- |
046 [1] 46 💬 |
221 |
Other: balance |
Isoxaflutole |
- |
- |
- |
006 [3] 6 , 13, 299 💬 |
222 |
Other: balance exercise |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
223 |
Other: balance exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
224 |
Other: balance trainer balance exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
225 |
Other: balance training |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
226 |
Other: baseline serum vitamin d level at or above 50 nmol/l |
Vitamin D |
- |
- |
- |
046 [1] 46 💬 |
227 |
Other: baseline serum vitamin d level below 50 nmol/l |
Vitamin D |
- |
- |
- |
046 [1] 46 💬 |
228 |
Other: beetroot juice extract |
- |
- |
- |
- |
113 [1] 113 💬 |
229 |
Other: berg balance scale |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
230 |
Other: best medical treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
231 |
Other: best practice |
- |
- |
- |
- |
060 [1] 60 💬 |
232 |
Other: biological samples |
- |
- |
- |
- |
206 [1] 206 💬 |
233 |
Other: biopsy |
- |
- |
- |
- |
051 [1] 51 💬 |
234 |
Other: blood collection for measurement of eculizumab peak concentrations |
Eculizumab |
[1] D03940 D03940 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 [1] 62 💬 |
235 |
Other: blood drawing only group c |
- |
- |
- |
- |
049 [1] 49 💬 |
236 |
Other: blood glucose results |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
237 |
Other: blood sample |
- |
- |
- |
- |
299 [1] 299 💬 |
238 |
Other: blood sample and cotton skin swabs |
Cotton |
- |
- |
- |
162 [1] 162 💬 |
239 |
Other: blood samples |
- |
- |
- |
- |
093 [1] 93 💬 |
240 |
Other: blood sampling for laboratory developed test (ldt) analysis |
- |
- |
- |
- |
065 [1] 65 💬 |
241 |
Other: blood test |
- |
- |
- |
- |
096 [1] 96 💬 |
242 |
Other: blood-flow restricted training |
- |
- |
- |
- |
015 [1] 15 💬 |
243 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (arterial blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 [1] 230 💬 |
244 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (venous blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 [1] 230 💬 |
245 |
Other: bone marrow cell transplantation |
- |
- |
- |
- |
274 [1] 274 💬 |
246 |
Other: brain mri (magnetic resonance imaging) |
- |
- |
- |
- |
017 [1] 17 💬 |
247 |
Other: brief pain inventory questionnaire |
- |
- |
- |
- |
019 [1] 19 💬 |
248 |
Other: bronchoalveolar samples |
- |
- |
- |
- |
051 [1] 51 💬 |
249 |
Other: caffeine |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
250 |
Other: calcium stable isotope |
Calcium |
- |
- |
- |
186 [1] 186 💬 |
251 |
Other: carbon monoxide-bubbled mediums |
Activated charcoal |
[2] D03251 D03251, D09706 D09706 💬 |
- |
- |
298 [1] 298 💬 |
252 |
Other: carboxy methyl cellulose |
Methylcellulose |
[2] D00093 D00093, D04996 D04996 💬 |
- |
- |
053 [1] 53 💬 |
253 |
Other: cardiopulmonary evaluation |
- |
- |
- |
- |
013 [1] 13 💬 |
254 |
Other: cawthorne cooksey exercises |
- |
- |
- |
- |
013 [1] 13 💬 |
255 |
Other: cd lfd |
- |
- |
- |
- |
096 [1] 96 💬 |
256 |
Other: cd-treat diet |
- |
- |
- |
- |
096 [1] 96 💬 |
257 |
Other: challenge agent: capsaicin |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
019 [1] 19 💬 |
258 |
Other: classic, progressive endurance training |
- |
- |
- |
- |
013 [1] 13 💬 |
259 |
Other: coa-z |
- |
- |
- |
- |
120 [1] 120 💬 |
260 |
Other: coaching sessions |
- |
- |
- |
- |
049 [1] 49 💬 |
261 |
Other: coduse balance training and step square exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
262 |
Other: coffee |
- |
- |
- |
- |
096 [1] 96 💬 |
263 |
Other: cognitive training |
- |
- |
- |
- |
206 [1] 206 💬 |
264 |
Other: colchicine cessation |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
266 [1] 266 💬 |
265 |
Other: collection of csf, blood, urine, saliva |
- |
- |
- |
- |
006 [1] 6 💬 |
266 |
Other: communicative effectiveness survey |
- |
- |
- |
- |
002 [1] 2 💬 |
267 |
Other: comparator: cpet cycle ergometer (gold standard) |
Gold |
- |
- |
- |
299 [1] 299 💬 |
268 |
Other: computer game based balance and walking rehabilitation for individuals with parkinson's disease |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
269 |
Other: concomitant medication |
- |
- |
- |
- |
049 [1] 49 💬 |
270 |
Other: continuation of dornase alfa (dnase) |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
271 |
Other: continuation of hypertonic saline (hs) |
- |
- |
- |
- |
299 [1] 299 💬 |
272 |
Other: continue their usual therapy |
- |
- |
- |
- |
066 [1] 66 💬 |
273 |
Other: control |
- |
- |
- |
- |
006 [8] 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
274 |
Other: control diet |
- |
- |
- |
- |
096 [1] 96 💬 |
275 |
Other: control group |
- |
- |
- |
- |
002 [1] 2 💬 |
276 |
Other: control group(normal saline) |
- |
- |
- |
- |
097 [1] 97 💬 |
277 |
Other: control wound treatment |
- |
- |
- |
- |
036 [1] 36 💬 |
278 |
Other: controlled environment tests (series of tasks of everyday life) |
- |
- |
- |
- |
006 [1] 6 💬 |
279 |
Other: controls primary cervical dystonia (trihexyphenidyl) |
Trihexyphenidyl |
[2] D00787 D00787, D08638 D08638 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
280 |
Other: conventional balance training |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
281 |
Other: conventional drugs |
- |
- |
- |
- |
097 [1] 97 💬 |
282 |
Other: conventional pca mode |
- |
- |
- |
- |
070 [1] 70 💬 |
283 |
Other: core stability |
- |
- |
- |
- |
013 [1] 13 💬 |
284 |
Other: corn starch |
Starch, corn |
[1] D05297 D05297 💬 |
- |
- |
049 [1] 49 💬 |
285 |
Other: corticotropin releasing hormone (crh) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
078 [1] 78 💬 |
286 |
Other: cough monitor |
Methamidophos |
- |
- |
- |
085 [1] 85 💬 |
287 |
Other: crohn's disease treatment-with-eating diet (cd-treat diet) |
- |
- |
- |
- |
096 [1] 96 💬 |
288 |
Other: crohns disease exclusion diet |
- |
- |
- |
- |
096 [1] 96 💬 |
289 |
Other: cultured thymus tissue implantation and parental parathyroid transplantation |
- |
- |
- |
- |
065 [1] 65 💬 |
290 |
Other: cultured thymus tissue implantation with parathyroid transplantation |
- |
- |
- |
- |
065 [1] 65 💬 |
291 |
Other: current treatment |
- |
- |
- |
- |
046 [1] 46 💬 |
292 |
Other: cyclosporin a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
293 |
Other: cysteamine bitartrate |
Cysteamine |
[2] D03634 D03634, D03635 D03635 💬 |
- |
- |
019 [1] 19 💬 |
294 |
Other: d-xylose |
Xylose |
[1] D06346 D06346 💬 |
- |
- |
098 [1] 98 💬 |
295 |
Other: d5w |
- |
- |
- |
- |
222 [1] 222 💬 |
296 |
Other: data capture |
Bifenthrin |
- |
- |
- |
006 [1] 6 💬 |
297 |
Other: dead sea solar and water treatment |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
298 |
Other: determination of calcium intake by a dietician interview |
Calcium |
- |
- |
- |
013 [2] 13, 46 💬 |
299 |
Other: dextrose water 5% |
Dextrose, unspecified form |
[1] D00001 D00001 💬 |
- |
- |
056 [1] 56 💬 |
300 |
Other: diagnostic laboratory biomarker analysis |
- |
- |
- |
- |
074 [1] 74 💬 |
301 |
Other: diagnostics for glucose tolerance with 3 different methods. |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
302 |
Other: diary completion |
- |
- |
- |
- |
006 [1] 6 💬 |
303 |
Other: diet |
- |
- |
- |
- |
240 [1] 240 💬 |
304 |
Other: diet treatment |
- |
- |
- |
- |
240 [1] 240 💬 |
305 |
Other: diet-cd |
- |
- |
- |
- |
096 [1] 96 💬 |
306 |
Other: dietary intervention with no-carrageenan diet |
- |
- |
- |
- |
097 [1] 97 💬 |
307 |
Other: discontinuation of dornase alfa (dnase) |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
308 |
Other: discontinuation of hypertonic saline (hs) |
- |
- |
- |
- |
299 [1] 299 💬 |
309 |
Other: dmt withdrawal |
- |
- |
- |
- |
013 [1] 13 💬 |
310 |
Other: dobutamine |
Dobutamine |
[4] D00632 D00632, D03879 D03879, D03880 D03880, D03881 D03881 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
215 [1] 215 💬 |
311 |
Other: donor derived g-csf mobilized pbc |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
060 [1] 60 💬 |
312 |
Other: donor lymphocyte infusion |
- |
- |
- |
- |
065 [1] 65 💬 |
313 |
Other: dose reduction to 2mg/l |
- |
- |
- |
- |
046 [1] 46 💬 |
314 |
Other: dose reduction to 5mg/l |
- |
- |
- |
- |
046 [1] 46 💬 |
315 |
Other: drug free |
- |
- |
- |
- |
049 [1] 49 💬 |
316 |
Other: dual task performance |
- |
- |
- |
- |
013 [1] 13 💬 |
317 |
Other: dummy tripterygium wilfordii hook f (twhf) |
Tripterygium wilfordii whole |
- |
- |
- |
046 [1] 46 💬 |
318 |
Other: dynamic balance training |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
319 |
Other: dystrophin levels |
- |
- |
- |
- |
113 [1] 113 💬 |
320 |
Other: dyt 1 dystonia |
- |
- |
- |
- |
006 [1] 6 💬 |
321 |
Other: dyt 1 dystonia (healthy control) |
- |
- |
- |
- |
006 [1] 6 💬 |
322 |
Other: e-monitoring |
- |
- |
- |
- |
097 [1] 97 💬 |
323 |
Other: eating assessment tool 10 |
- |
- |
- |
- |
002 [1] 2 💬 |
324 |
Other: eating assessment tool-10 |
- |
- |
- |
- |
002 [1] 2 💬 |
325 |
Other: echocardiogram |
- |
- |
- |
- |
113 [1] 113 💬 |
326 |
Other: eculizumab |
Eculizumab |
[1] D03940 D03940 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
109 [1] 109 💬 |
327 |
Other: eit |
- |
- |
- |
- |
228 [1] 228 💬 |
328 |
Other: electroencephalogram (eeg) awake andextended overnight |
- |
- |
- |
- |
019 [1] 19 💬 |
329 |
Other: elimination diet |
- |
- |
- |
- |
098 [1] 98 💬 |
330 |
Other: empiric use of calcium carbonate and calcitriol |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
331 |
Other: endurance |
- |
- |
- |
- |
006 [1] 6 💬 |
332 |
Other: enteral nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
333 |
Other: epiduroscopy |
- |
- |
- |
- |
070 [1] 70 💬 |
334 |
Other: epistaxis charts |
- |
- |
- |
- |
227 [1] 227 💬 |
335 |
Other: eus procedure |
- |
- |
- |
- |
298 [1] 298 💬 |
336 |
Other: evaluation by investigator |
- |
- |
- |
- |
006 [1] 6 💬 |
337 |
Other: evaluation of degree chronic fatigue. |
- |
- |
- |
- |
013 [1] 13 💬 |
338 |
Other: event-related evoked potential using electroencephalography (eeg). |
- |
- |
- |
- |
006 [1] 6 💬 |
339 |
Other: exclusion diet |
- |
- |
- |
- |
096 [1] 96 💬 |
340 |
Other: exclusive enteral nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
341 |
Other: exclusive enteral nutrition (een) |
- |
- |
- |
- |
096 [1] 96 💬 |
342 |
Other: exercise capacity |
- |
- |
- |
- |
299 [1] 299 💬 |
343 |
Other: exercise echocardiography |
- |
- |
- |
- |
058 [1] 58 💬 |
344 |
Other: exercise followed cold water immersion |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
345 |
Other: exercise intervention |
- |
- |
- |
- |
013 [2] 13, 18 💬 |
346 |
Other: faecal bacterial transplantation |
- |
- |
- |
- |
097 [1] 97 💬 |
347 |
Other: fast mimicking diet |
- |
- |
- |
- |
097 [1] 97 💬 |
348 |
Other: fatigue |
- |
- |
- |
- |
013 [1] 13 💬 |
349 |
Other: fear of falling |
- |
- |
- |
- |
013 [1] 13 💬 |
350 |
Other: fingolimod |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
351 |
Other: fitbit activity monitor |
Methamidophos |
- |
- |
- |
049 [1] 49 💬 |
352 |
Other: flow cytometry |
- |
- |
- |
- |
028 [3] 28, 51, 60 💬 |
353 |
Other: fluid restriction |
- |
- |
- |
- |
072 [1] 72 💬 |
354 |
Other: fluorescein angiography |
Fluorescein |
[2] D01261 D01261, D02024 D02024 💬 |
- |
- |
019 [1] 19 💬 |
355 |
Other: fog |
- |
- |
- |
- |
006 [1] 6 💬 |
356 |
Other: food diary |
- |
- |
- |
- |
065 [1] 65 💬 |
357 |
Other: four square step test |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
358 |
Other: fractional exhaled no (feno) |
- |
- |
- |
- |
096 [1] 96 💬 |
359 |
Other: fresh frozen plasma |
- |
- |
- |
- |
014 [1] 14 💬 |
360 |
Other: fruit juice |
- |
- |
- |
- |
299 [1] 299 💬 |
361 |
Other: functional involvement of identified epigenetic alterations |
- |
- |
- |
- |
102 [1] 102 💬 |
362 |
Other: functional mobility |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
363 |
Other: functional oral intake scale |
- |
- |
- |
- |
002 [1] 2 💬 |
364 |
Other: functional reach test |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
365 |
Other: gadobutrol |
Gadobutrol |
[1] D07420 D07420 💬 |
- |
- |
046 [1] 46 💬 |
366 |
Other: gait and balance group training |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
367 |
Other: general and neurological examination |
- |
- |
- |
- |
019 [1] 19 💬 |
368 |
Other: general population |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
369 |
Other: generation of induced pluripotent stem cells (ipsc) from fibroblasts obtained by skin biopsy |
- |
- |
- |
- |
102 [1] 102 💬 |
370 |
Other: gh pause |
- |
- |
- |
- |
078 [1] 78 💬 |
371 |
Other: ghrh plus arginine test |
Arginine |
[2] D02982 D02982, D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
372 |
Other: ghrh+arg, ghrh+arg, itt |
Somatorelin |
[1] D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
373 |
Other: glucose |
Dextrose, unspecified form |
- |
- |
- |
254 [1] 254 💬 |
374 |
Other: glucose -potentiated arginine (gpa) stimulation tests |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
299 [1] 299 💬 |
375 |
Other: glucose profile for 2 weeks |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
376 |
Other: glucose solution at a dose of 1.75 g/kg (up to a maximum of 75 g) for the ogtt and glucose solution at a dose of 0.5 g/kg (up to a maximum of 35 g) was injected in 2.5-3 min for the igtt |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
377 |
Other: glycerine gel |
Glycerin |
[1] D00028 D00028 💬 |
- |
- |
265 [1] 265 💬 |
378 |
Other: green tea (camellia sinensis) |
Green tea leaf |
[1] D06903 D06903 💬 |
- |
- |
096 [1] 96 💬 |
379 |
Other: group 2 (dmards treated group) |
- |
- |
- |
- |
046 [1] 46 💬 |
380 |
Other: group b sle one blood donation |
- |
- |
- |
- |
049 [1] 49 💬 |
381 |
Other: group balance training |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
382 |
Other: group exercise: community setting |
- |
- |
- |
- |
070 [1] 70 💬 |
383 |
Other: growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
384 |
Other: gsk2586184 single dose taken with food |
- |
- |
- |
- |
049 [1] 49 💬 |
385 |
Other: gsk2586184 single dose taken without food |
- |
- |
- |
- |
049 [1] 49 💬 |
386 |
Other: haematopoietic stem cell transplantation (hsct) |
- |
- |
- |
- |
065 [1] 65 💬 |
387 |
Other: hand training |
- |
- |
- |
- |
046 [1] 46 💬 |
388 |
Other: harkány medicinal water |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
389 |
Other: healthy controls |
- |
- |
- |
- |
063 [1] 63 💬 |
390 |
Other: healthy volunteers |
- |
- |
- |
- |
046 [1] 46 💬 |
391 |
Other: hemicellulose crystalline |
- |
- |
- |
- |
006 [1] 6 💬 |
392 |
Other: hepatic elastography |
- |
- |
- |
- |
299 [1] 299 💬 |
393 |
Other: high energy / protein diet. |
- |
- |
- |
- |
096 [1] 96 💬 |
394 |
Other: high glycemic index meal |
- |
- |
- |
- |
299 [1] 299 💬 |
395 |
Other: high intensity exercise and balance training |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
396 |
Other: high performance liquid chromatography |
- |
- |
- |
- |
096 [1] 96 💬 |
397 |
Other: high resolution peripheral quantitative computed tomography (hrpqct) |
- |
- |
- |
- |
172 [1] 172 💬 |
398 |
Other: high water intake |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
399 |
Other: high-impact exercise intervention |
- |
- |
- |
- |
096 [1] 96 💬 |
400 |
Other: histamine |
Histamine |
[1] D08040 D08040 💬 |
HRH1 [4] HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
401 |
Other: histone acetylation profiles of cells of srt patients with crebbp mutations |
- |
- |
- |
- |
102 [1] 102 💬 |
402 |
Other: historical control |
- |
- |
- |
- |
002 [1] 2 💬 |
403 |
Other: hoehn and yahr scale |
- |
- |
- |
- |
006 [1] 6 💬 |
404 |
Other: honey |
Honey |
[1] D06776 D06776 💬 |
- |
- |
098 [1] 98 💬 |
405 |
Other: human milk derived fortifier |
Cow milk |
- |
- |
- |
210 [1] 210 💬 |
406 |
Other: human umbilical cord-derived mscs and cyclosporin a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
407 |
Other: human/bovine milk |
Cow milk |
- |
- |
- |
210 [1] 210 💬 |
408 |
Other: hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
409 |
Other: hydrogen peroxide |
Hydrogen |
[1] D00008 D00008 💬 |
- |
- |
013 [1] 13 💬 |
410 |
Other: hydroxychloroquine/chloroquine |
Chloroquine |
[4] D02125 D02125, D02366 D02366, D03469 D03469, D08050 D08050 💬 |
- |
- |
046 [1] 46 💬 |
411 |
Other: hyperbaric oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
096 [1] 96 💬 |
412 |
Other: hyperbaric oxygen therapy |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
097 [2] 97, 226 💬 |
413 |
Other: hyperpolarized xenon mri |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
299 [1] 299 💬 |
414 |
Other: hypoglycemic clamp |
- |
- |
- |
- |
299 [1] 299 💬 |
415 |
Other: ibuprofen and isosorbide dinitrate combination |
Ibuprofen |
[6] D00126 D00126, D00347 D00347, D00516 D00516, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 [1] 113 💬 |
416 |
Other: iloprost (ventavis inhaled, bayq6256) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
417 |
Other: imaging |
- |
- |
- |
- |
013 [1] 13 💬 |
418 |
Other: imitation surgical procedure (isp) |
- |
- |
- |
- |
006 [1] 6 💬 |
419 |
Other: immunologic technique |
- |
- |
- |
- |
049 [1] 49 💬 |
420 |
Other: impact of biotherapy on postoperative morbidity in ulcerative colitis |
- |
- |
- |
- |
097 [1] 97 💬 |
421 |
Other: impact peptide 1.5 |
- |
- |
- |
- |
299 [1] 299 💬 |
422 |
Other: inactive drug |
- |
- |
- |
- |
226 [1] 226 💬 |
423 |
Other: incontinence severity |
- |
- |
- |
- |
013 [1] 13 💬 |
424 |
Other: individualized exercises: clinical setting |
- |
- |
- |
- |
070 [1] 70 💬 |
425 |
Other: induced hypotonic hyponatremia - siad model |
- |
- |
- |
- |
072 [1] 72 💬 |
426 |
Other: infliximab (ifx) infusion |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
427 |
Other: inhalable hypertonic saline 7% |
- |
- |
- |
- |
299 [1] 299 💬 |
428 |
Other: inhalable hypertonic saline 7% + hyaluronan 0.1% |
Hyaluronic acid |
[1] D08043 D08043 💬 |
- |
- |
299 [1] 299 💬 |
429 |
Other: inhaled hyperpolarized xenon-129 |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
228 [1] 228 💬 |
430 |
Other: intensify treatment with the existing drug |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
431 |
Other: intensive supportive care |
- |
- |
- |
- |
066 [1] 66 💬 |
432 |
Other: intrathecal saline injection |
- |
- |
- |
- |
013 [1] 13 💬 |
433 |
Other: isa 51 |
- |
- |
- |
- |
050 [1] 50 💬 |
434 |
Other: isa 51 vg |
- |
- |
- |
- |
049 [1] 49 💬 |
435 |
Other: itt, itt, ghrh+arg. |
Somatorelin |
[1] D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
436 |
Other: iv saline infusion |
- |
- |
- |
- |
096 [1] 96 💬 |
437 |
Other: iv steroids combination alone |
- |
- |
- |
- |
041 [1] 41 💬 |
438 |
Other: ivig |
Human immunoglobulin G |
- |
- |
- |
035 [1] 35 💬 |
439 |
Other: joint mobilizations (spine, sacroiliac, hip) |
- |
- |
- |
- |
070 [1] 70 💬 |
440 |
Other: ketogenic diet |
- |
- |
- |
- |
019 [1] 19 💬 |
441 |
Other: lab work |
- |
- |
- |
- |
046 [1] 46 💬 |
442 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 [21] 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
443 |
Other: language intervention |
- |
- |
- |
- |
206 [1] 206 💬 |
444 |
Other: lengthening adalimumab dosing interval |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
445 |
Other: leukapheresis- collection of stem cells |
- |
- |
- |
- |
096 [1] 96 💬 |
446 |
Other: levothyroxine |
Levothyroxine |
[2] D01010 D01010, D08125 D08125 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
078 [1] 78 💬 |
447 |
Other: liberation therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
448 |
Other: liquid meal test (carbohydrate-rich) |
- |
- |
- |
- |
299 [1] 299 💬 |
449 |
Other: liquid meal test (fat-rich) |
- |
- |
- |
- |
299 [1] 299 💬 |
450 |
Other: liquid meal test (mixed) |
- |
- |
- |
- |
299 [1] 299 💬 |
451 |
Other: liver evaluation |
- |
- |
- |
- |
240 [1] 240 💬 |
452 |
Other: liver questionnaire |
- |
- |
- |
- |
231 [1] 231 💬 |
453 |
Other: losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
454 |
Other: low blood pressure control |
- |
- |
- |
- |
067 [1] 67 💬 |
455 |
Other: low dose (1 mcg) acth stimulation test |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
193 [1] 193 💬 |
456 |
Other: low glycemic index meal |
- |
- |
- |
- |
299 [1] 299 💬 |
457 |
Other: low n-6 pufa diet |
- |
- |
- |
- |
096 [1] 96 💬 |
458 |
Other: low-intensity exercise therapy |
- |
- |
- |
- |
298 [1] 298 💬 |
459 |
Other: lower limb strength |
- |
- |
- |
- |
006 [1] 6 💬 |
460 |
Other: magnetic resonance imaging (mri) |
- |
- |
- |
- |
113 [1] 113 💬 |
461 |
Other: mangafodipir trisodium |
Mangafodipir |
[1] D08262 D08262 💬 |
- |
- |
058 [1] 58 💬 |
462 |
Other: meal challenge |
- |
- |
- |
- |
240 [1] 240 💬 |
463 |
Other: measure of endothelial function |
- |
- |
- |
- |
299 [1] 299 💬 |
464 |
Other: measurement of drug (adalimumab/infliximab) |
Adalimumab |
[2] D02597 D02597, D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
465 |
Other: medical air |
Medical air |
- |
- |
- |
085 [1] 85 💬 |
466 |
Other: medical chart review |
- |
- |
- |
- |
060 [1] 60 💬 |
467 |
Other: medical history questionnaires |
- |
- |
- |
- |
065 [1] 65 💬 |
468 |
Other: medication compliance phone call |
- |
- |
- |
- |
098 [1] 98 💬 |
469 |
Other: mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
470 |
Other: metabolic exercise testing using stationary bicycle |
- |
- |
- |
- |
113 [1] 113 💬 |
471 |
Other: metformin |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
046 [1] 46 💬 |
472 |
Other: methacholine challenge test |
Methacholine |
- |
- |
- |
096 [1] 96 💬 |
473 |
Other: methotrexate therapy |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
474 |
Other: mibg label with i123 or i124 |
- |
- |
- |
- |
006 [1] 6 💬 |
475 |
Other: microindentation |
- |
- |
- |
- |
172 [1] 172 💬 |
476 |
Other: mitoxantrone - immunomodulator |
Mitoxantrone |
[2] D02166 D02166, D08224 D08224 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
013 [1] 13 💬 |
477 |
Other: mixed meal test evaluation test arm |
- |
- |
- |
- |
299 [1] 299 💬 |
478 |
Other: mixed meal tolerance test |
- |
- |
- |
- |
299 [1] 299 💬 |
479 |
Other: mobile platform exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
480 |
Other: mock injection |
- |
- |
- |
- |
090 [1] 90 💬 |
481 |
Other: modified atkins diet |
- |
- |
- |
- |
145 [1] 145 💬 |
482 |
Other: modified mixed meal tolerance test |
- |
- |
- |
- |
065 [1] 65 💬 |
483 |
Other: modified oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
065 [1] 65 💬 |
484 |
Other: modified paleolithic diet |
- |
- |
- |
- |
013 [1] 13 💬 |
485 |
Other: monthly assessments of functional motor abilities by a trained therapist |
- |
- |
- |
- |
003 [1] 3 💬 |
486 |
Other: motor assessments before taking regular pd treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
487 |
Other: motor assessments on regular pd treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
488 |
Other: mp+ddci |
- |
- |
- |
- |
006 [1] 6 💬 |
489 |
Other: mp-equivalent |
- |
- |
- |
- |
006 [1] 6 💬 |
490 |
Other: mp-low |
- |
- |
- |
- |
006 [1] 6 💬 |
491 |
Other: mri |
- |
- |
- |
- |
006 [3] 6 , 127, 206 💬 |
492 |
Other: multidisciplinary intensive rehabilitation treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
493 |
Other: muscle oxygenation |
- |
- |
- |
- |
299 [1] 299 💬 |
494 |
Other: music |
- |
- |
- |
- |
006 [1] 6 💬 |
495 |
Other: mybetaapp |
- |
- |
- |
- |
013 [1] 13 💬 |
496 |
Other: natalizumab |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
497 |
Other: natalizumab discontinuation |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
498 |
Other: natural herbs of coconut, aloe vera, and pepperint |
Aloe Vera Leaf |
- |
- |
- |
053 [1] 53 💬 |
499 |
Other: nbt-nm108 (0 g/day) |
- |
- |
- |
- |
013 [1] 13 💬 |
500 |
Other: neupro 4 mg / 24 hr. transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
501 |
Other: neurology exam |
- |
- |
- |
- |
019 [1] 19 💬 |
502 |
Other: neuromuscular evaluation |
- |
- |
- |
- |
013 [1] 13 💬 |
503 |
Other: nil per os |
- |
- |
- |
- |
291 [1] 291 💬 |
504 |
Other: nintendo wii fit balance exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
505 |
Other: no active treatment |
- |
- |
- |
- |
274 [1] 274 💬 |
506 |
Other: no anti-inflammatory treatment |
- |
- |
- |
- |
271 [1] 271 💬 |
507 |
Other: no device |
- |
- |
- |
- |
013 [1] 13 💬 |
508 |
Other: no doxycycline |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
299 [1] 299 💬 |
509 |
Other: no enzyme therapy |
- |
- |
- |
- |
298 [1] 298 💬 |
510 |
Other: no intervention |
- |
- |
- |
- |
070 [1] 70 💬 |
511 |
Other: no intervention: standard of care |
- |
- |
- |
- |
085 [1] 85 💬 |
512 |
Other: no it treatment |
- |
- |
- |
- |
019 [1] 19 💬 |
513 |
Other: no msdmds therapy (control) |
- |
- |
- |
- |
013 [1] 13 💬 |
514 |
Other: no pancreatic enzyme replacement therapy |
- |
- |
- |
- |
299 [1] 299 💬 |
515 |
Other: no plasma exchange |
- |
- |
- |
- |
043 [2] 43, 44 💬 |
516 |
Other: no treatment |
- |
- |
- |
- |
053 [2] 53, 256 💬 |
517 |
Other: no treatment arm |
- |
- |
- |
- |
013 [1] 13 💬 |
518 |
Other: no treatment given |
- |
- |
- |
- |
078 [1] 78 💬 |
519 |
Other: non impact aerobics |
- |
- |
- |
- |
013 [1] 13 💬 |
520 |
Other: non-hormonal period |
- |
- |
- |
- |
299 [1] 299 💬 |
521 |
Other: non-motor symptoms |
- |
- |
- |
- |
006 [1] 6 💬 |
522 |
Other: noninvasive actigraphy monitor |
Methamidophos |
- |
- |
- |
086 [1] 86 💬 |
523 |
Other: nordic walking (only osteoporosis group) |
- |
- |
- |
- |
006 [1] 6 💬 |
524 |
Other: normal (control) diet |
- |
- |
- |
- |
240 [1] 240 💬 |
525 |
Other: normal diet |
- |
- |
- |
- |
096 [1] 96 💬 |
526 |
Other: normal saline |
- |
- |
- |
- |
013 [4] 13, 222, 226, 280 💬 |
527 |
Other: normal saline for injection |
- |
- |
- |
- |
084 [1] 84 💬 |
528 |
Other: ns |
- |
- |
- |
- |
096 [1] 96 💬 |
529 |
Other: numerical rating scale |
- |
- |
- |
- |
046 [1] 46 💬 |
530 |
Other: nutrition counseling |
- |
- |
- |
- |
298 [1] 298 💬 |
531 |
Other: obese |
- |
- |
- |
- |
075 [1] 75 💬 |
532 |
Other: observation |
- |
- |
- |
- |
265 [1] 265 💬 |
533 |
Other: observation of ocrelizumab as treatment in rrms patients |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
534 |
Other: observation only |
- |
- |
- |
- |
331 [1] 331 💬 |
535 |
Other: observational |
- |
- |
- |
- |
090 [1] 90 💬 |
536 |
Other: observational cohort |
- |
- |
- |
- |
006 [1] 6 💬 |
537 |
Other: observational control |
- |
- |
- |
- |
013 [1] 13 💬 |
538 |
Other: ogtt |
- |
- |
- |
- |
299 [1] 299 💬 |
539 |
Other: on-demand treatment |
- |
- |
- |
- |
299 [1] 299 💬 |
540 |
Other: one-leg stance test |
- |
- |
- |
- |
013 [1] 13 💬 |
541 |
Other: ophthalmologic examinations |
- |
- |
- |
- |
299 [1] 299 💬 |
542 |
Other: optimized supportive care |
- |
- |
- |
- |
066 [1] 66 💬 |
543 |
Other: optimizing basal infusion (b.i) |
- |
- |
- |
- |
070 [1] 70 💬 |
544 |
Other: optional blood-oxygen-level dependent functionalmri |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [1] 6 💬 |
545 |
Other: oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
160 [3] 160, 195, 299 💬 |
546 |
Other: oral glucose tolerance test (ogtt) assessment arm |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
547 |
Other: oral nitric oxide testing |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
098 [1] 98 💬 |
548 |
Other: other biologic agents |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
549 |
Other: other intervention(s) |
- |
- |
- |
- |
070 [1] 70 💬 |
550 |
Other: other: disease modifying therapies (dmt) |
- |
- |
- |
- |
013 [1] 13 💬 |
551 |
Other: other: symptomatic treatment of als |
- |
- |
- |
- |
002 [1] 2 💬 |
552 |
Other: outpatient rheumatology department |
- |
- |
- |
- |
046 [1] 46 💬 |
553 |
Other: overnight metyrapone test |
Metyrapone |
[2] D00410 D00410, D05019 D05019 💬 |
CYP11B1 [1] CYP11B1 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis |
193 [1] 193 💬 |
554 |
Other: oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
555 |
Other: oxygen (2liter/min) |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
556 |
Other: oxygen (4liter/min) |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
557 |
Other: oxygen - air |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
558 |
Other: oxygen supplementation |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
086 [1] 86 💬 |
559 |
Other: packing |
- |
- |
- |
- |
227 [1] 227 💬 |
560 |
Other: pain |
- |
- |
- |
- |
013 [1] 13 💬 |
561 |
Other: palliative care |
- |
- |
- |
- |
019 [5] 19, 65, 120, 160, 326 💬 |
562 |
Other: parkinson mpower mobile application |
- |
- |
- |
- |
006 [1] 6 💬 |
563 |
Other: passive : lecture series |
- |
- |
- |
- |
013 [1] 13 💬 |
564 |
Other: pcdai |
- |
- |
- |
- |
096 [1] 96 💬 |
565 |
Other: pd exercise intervention |
- |
- |
- |
- |
006 [1] 6 💬 |
566 |
Other: pd vitamin + exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
567 |
Other: peak |
- |
- |
- |
- |
013 [1] 13 💬 |
568 |
Other: peanut butter |
Peanut |
- |
- |
- |
013 [1] 13 💬 |
569 |
Other: pentadecanoic acid (pa) and triheptadecanoin (tha) |
- |
- |
- |
- |
299 [1] 299 💬 |
570 |
Other: pentasa (mesalamine/ 5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
571 |
Other: periodized exercise training |
- |
- |
- |
- |
013 [1] 13 💬 |
572 |
Other: pharmacogenomic study |
- |
- |
- |
- |
026 [1] 26 💬 |
573 |
Other: pharmacokinetic analysis |
- |
- |
- |
- |
049 [1] 49 💬 |
574 |
Other: pharmacological study |
- |
- |
- |
- |
028 [7] 28, 34, 62, 74, 89, 232, 331 💬 |
575 |
Other: phenylalanine (phe)-restricted diet |
Phenylalanine |
[1] D00021 D00021 💬 |
- |
- |
240 [1] 240 💬 |
576 |
Other: physalis angulata ethanol extract |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 [1] 51 💬 |
577 |
Other: physical function performance test |
- |
- |
- |
- |
006 [1] 6 💬 |
578 |
Other: physical therapy |
- |
- |
- |
- |
006 [2] 6 , 70 💬 |
579 |
Other: pittsburgh compound b [11c]-pib |
Pittsburgh Compound B |
- |
- |
- |
006 [1] 6 💬 |
580 |
Other: plant-based diet |
- |
- |
- |
- |
046 [1] 46 💬 |
581 |
Other: plasticity-based computerized cognitive remediation program |
- |
- |
- |
- |
013 [1] 13 💬 |
582 |
Other: pnf |
- |
- |
- |
- |
013 [1] 13 💬 |
583 |
Other: position sense |
- |
- |
- |
- |
013 [1] 13 💬 |
584 |
Other: postoperative nausea and vomiting at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
585 |
Other: postoperative nausea and vomiting at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
586 |
Other: postoperative pain at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
587 |
Other: postoperative pain at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
588 |
Other: postoperative sore throat and hoarseness at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
589 |
Other: postoperative sore throat and hoarseness at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
590 |
Other: potable water |
Water |
[1] D00001 D00001 💬 |
- |
- |
019 [1] 19 💬 |
591 |
Other: prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
592 |
Other: pretreatment antibiotics |
- |
- |
- |
- |
097 [1] 97 💬 |
593 |
Other: progressive exercise |
- |
- |
- |
- |
013 [1] 13 💬 |
594 |
Other: propensity score |
- |
- |
- |
- |
013 [1] 13 💬 |
595 |
Other: prospective observational registry |
- |
- |
- |
- |
003 [1] 3 💬 |
596 |
Other: psp |
- |
- |
- |
- |
013 [1] 13 💬 |
597 |
Other: pth based calcium carbonate and calcitriol repletion |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
598 |
Other: pulmonary function testing (pft) |
- |
- |
- |
- |
113 [1] 113 💬 |
599 |
Other: pulmonary rehabilitation program |
- |
- |
- |
- |
085 [1] 85 💬 |
600 |
Other: qalcimum questionnaire |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
601 |
Other: quality of life assessment |
- |
- |
- |
- |
122 [1] 122 💬 |
602 |
Other: quality of life questionnaire |
- |
- |
- |
- |
019 [1] 19 💬 |
603 |
Other: quality-of-life assessment |
- |
- |
- |
- |
034 [5] 34, 36, 51, 96, 298 💬 |
604 |
Other: quercetin |
Quercetin |
- |
- |
- |
299 [1] 299 💬 |
605 |
Other: questionnaire administration |
- |
- |
- |
- |
016 [4] 16, 34, 51, 298 💬 |
606 |
Other: questionnaires |
- |
- |
- |
- |
006 [5] 6 , 13, 41, 93, 96 💬 |
607 |
Other: reaction time and postural control |
- |
- |
- |
- |
299 [1] 299 💬 |
608 |
Other: real-time data capture app |
Bifenthrin |
- |
- |
- |
046 [1] 46 💬 |
609 |
Other: recommendation with regard to nutrition |
- |
- |
- |
- |
006 [1] 6 💬 |
610 |
Other: reduction group 1 |
- |
- |
- |
- |
046 [1] 46 💬 |
611 |
Other: reduction group 2 |
- |
- |
- |
- |
046 [1] 46 💬 |
612 |
Other: refered to general practice |
- |
- |
- |
- |
046 [1] 46 💬 |
613 |
Other: resistance exercise program |
- |
- |
- |
- |
046 [1] 46 💬 |
614 |
Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry. |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
149 [1] 149 💬 |
615 |
Other: rhythmic auditory stimulation (ras) |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
616 |
Other: rhythmic balance-movement training (rbmt) |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
617 |
Other: rmst |
- |
- |
- |
- |
256 [1] 256 💬 |
618 |
Other: rosemary essential oil |
Rosemary |
- |
- |
- |
051 [1] 51 💬 |
619 |
Other: rotigotine |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
620 |
Other: routine |
- |
- |
- |
- |
240 [1] 240 💬 |
621 |
Other: routine management |
- |
- |
- |
- |
291 [1] 291 💬 |
622 |
Other: routine therapy |
- |
- |
- |
- |
299 [1] 299 💬 |
623 |
Other: rp% measurement by fcm as a diagnostic test for itp |
- |
- |
- |
- |
063 [1] 63 💬 |
624 |
Other: salbutamol nebulisation and with cpap |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
625 |
Other: saline |
- |
- |
- |
- |
002 [8] 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
626 |
Other: saline as a nasal spray |
- |
- |
- |
- |
226 [1] 226 💬 |
627 |
Other: saline solution |
- |
- |
- |
- |
067 [1] 67 💬 |
628 |
Other: saline solution. |
- |
- |
- |
- |
067 [1] 67 💬 |
629 |
Other: screening to prevent falls |
- |
- |
- |
- |
006 [1] 6 💬 |
630 |
Other: serum calcium concentrations results |
Calcium |
- |
- |
- |
235 [1] 235 💬 |
631 |
Other: serum levels of angiogenin, bfgf, vegf |
Basic Fibroblast Growth Factor |
- |
- |
- |
056 [1] 56 💬 |
632 |
Other: sham |
- |
- |
- |
- |
019 [2] 19, 301 💬 |
633 |
Other: sham (no implant) |
- |
- |
- |
- |
090 [1] 90 💬 |
634 |
Other: sham abdominal compression |
- |
- |
- |
- |
017 [1] 17 💬 |
635 |
Other: sham comparator |
- |
- |
- |
- |
299 [1] 299 💬 |
636 |
Other: sham group |
- |
- |
- |
- |
006 [1] 6 💬 |
637 |
Other: sham procedure |
- |
- |
- |
- |
090 [1] 90 💬 |
638 |
Other: sham surgery |
- |
- |
- |
- |
006 [1] 6 💬 |
639 |
Other: sham-procedure (dose cohort 1&2 only) |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
640 |
Other: simvastatin |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
046 [1] 46 💬 |
641 |
Other: sle treatment |
- |
- |
- |
- |
049 [1] 49 💬 |
642 |
Other: smartphone application |
- |
- |
- |
- |
049 [1] 49 💬 |
643 |
Other: smartphone-based balance exercises |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
644 |
Other: sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
051 [1] 51 💬 |
645 |
Other: specific sl-therapy |
- |
- |
- |
- |
006 [1] 6 💬 |
646 |
Other: specifically design 6 month resistance training program |
- |
- |
- |
- |
013 [1] 13 💬 |
647 |
Other: spinning grp |
- |
- |
- |
- |
013 [1] 13 💬 |
648 |
Other: sputum sample |
- |
- |
- |
- |
299 [1] 299 💬 |
649 |
Other: standard |
- |
- |
- |
- |
067 [1] 67 💬 |
650 |
Other: standard blood pressure control |
- |
- |
- |
- |
067 [1] 67 💬 |
651 |
Other: standard care |
- |
- |
- |
- |
227 [1] 227 💬 |
652 |
Other: standard immune suppression, oral |
- |
- |
- |
- |
228 [1] 228 💬 |
653 |
Other: standard nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
654 |
Other: standard of care |
- |
- |
- |
- |
013 [7] 13, 49, 64, 85, 96, 245, 246 💬 |
655 |
Other: standard of care (soc) |
- |
- |
- |
- |
062 [1] 62 💬 |
656 |
Other: standard of care sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
090 [2] 90, 301 💬 |
657 |
Other: standard steroid treatment |
- |
- |
- |
- |
113 [1] 113 💬 |
658 |
Other: standard therapy |
- |
- |
- |
- |
049 [1] 49 💬 |
659 |
Other: standard treatment |
- |
- |
- |
- |
227 [1] 227 💬 |
660 |
Other: standard treatment according to the clinical protocols |
- |
- |
- |
- |
049 [1] 49 💬 |
661 |
Other: standard-of-care |
- |
- |
- |
- |
086 [1] 86 💬 |
662 |
Other: standardized meals |
- |
- |
- |
- |
086 [1] 86 💬 |
663 |
Other: standardized scales: mds-updrs (part ii to iv) and rdrs |
- |
- |
- |
- |
006 [1] 6 💬 |
664 |
Other: static balance test |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
665 |
Other: stem cell transplant |
- |
- |
- |
- |
096 [1] 96 💬 |
666 |
Other: sterile normal saline (0.9% nacl) |
- |
- |
- |
- |
231 [1] 231 💬 |
667 |
Other: sterile saline |
- |
- |
- |
- |
046 [1] 46 💬 |
668 |
Other: stool sample |
- |
- |
- |
- |
006 [2] 6 , 299 💬 |
669 |
Other: strength training |
- |
- |
- |
- |
013 [1] 13 💬 |
670 |
Other: subacute hypoxic exposures |
- |
- |
- |
- |
086 [1] 86 💬 |
671 |
Other: subconjunctival injection of saline |
- |
- |
- |
- |
090 [1] 90 💬 |
672 |
Other: sugar pill |
- |
- |
- |
- |
090 [1] 90 💬 |
673 |
Other: sulfur pool & medicinal mud |
- |
- |
- |
- |
046 [1] 46 💬 |
674 |
Other: supervised physical therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
675 |
Other: surgery |
- |
- |
- |
- |
074 [2] 74, 96 💬 |
676 |
Other: swallowing quality of life questionnaire |
- |
- |
- |
- |
002 [1] 2 💬 |
677 |
Other: swallowing related quality of life questionnaire |
- |
- |
- |
- |
002 [1] 2 💬 |
678 |
Other: symptom survey |
- |
- |
- |
- |
098 [1] 98 💬 |
679 |
Other: symptomatic hypocalcaemia at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
680 |
Other: symptomatic hypocalcaemia at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
681 |
Other: t-dcs group |
- |
- |
- |
- |
006 [1] 6 💬 |
682 |
Other: tampa kinesiophobia scale, berg-balance test, international physical activity questionnaire-short form, falls efficacy scale |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
683 |
Other: technetium [tc-99m] sulfur colloid and indium [in-111] dtpa |
Indium |
[1] D05422 D05422 💬 |
- |
- |
299 [1] 299 💬 |
684 |
Other: test soda |
- |
- |
- |
- |
299 [1] 299 💬 |
685 |
Other: the center for neurologic studies bulbar function scale |
- |
- |
- |
- |
002 [1] 2 💬 |
686 |
Other: the center for neurologic study bulbar function scale |
- |
- |
- |
- |
002 [1] 2 💬 |
687 |
Other: the patients' parents have to complete the vineland ii adaptive behavior scales scoring, the sleep disturbance scale for children (sdsc) and horne & ostberg circadian typology questionnaire |
- |
- |
- |
- |
149 [1] 149 💬 |
688 |
Other: the timed 360° turn test |
- |
- |
- |
- |
006 [1] 6 💬 |
689 |
Other: therapy education |
- |
- |
- |
- |
097 [1] 97 💬 |
690 |
Other: threonine |
Threonine |
[1] D00041 D00041 💬 |
- |
- |
096 [2] 96, 97 💬 |
691 |
Other: timed up an go test |
- |
- |
- |
- |
013 [1] 13 💬 |
692 |
Other: timed up and go test |
- |
- |
- |
- |
006 [1] 6 💬 |
693 |
Other: tobacco questionnaire |
Tobacco leaf |
- |
- |
- |
299 [1] 299 💬 |
694 |
Other: tobramycin time of administration |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
695 |
Other: training groupe |
- |
- |
- |
- |
013 [1] 13 💬 |
696 |
Other: transthoracic echocardiography at rest, during plr, hg and cpx (including blood gas analysis in both groups). additionally fallot patients will undergo routine blood testings. |
- |
- |
- |
- |
215 [1] 215 💬 |
697 |
Other: triangular test |
- |
- |
- |
- |
096 [1] 96 💬 |
698 |
Other: trunk impairment |
- |
- |
- |
- |
013 [1] 13 💬 |
699 |
Other: trunk impairment scale |
- |
- |
- |
- |
006 [1] 6 💬 |
700 |
Other: trunk position sense |
- |
- |
- |
- |
013 [1] 13 💬 |
701 |
Other: tyramine |
Tyramine |
- |
- |
- |
006 [1] 6 💬 |
702 |
Other: uc-mscs by peripheral intravenous infusion |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
096 [1] 96 💬 |
703 |
Other: ulcerative colitis diet |
- |
- |
- |
- |
097 [1] 97 💬 |
704 |
Other: ultrasonography assessment |
- |
- |
- |
- |
049 [1] 49 💬 |
705 |
Other: unified parkinson's disease rating scale |
- |
- |
- |
- |
006 [1] 6 💬 |
706 |
Other: untreated cohort |
- |
- |
- |
- |
085 [1] 85 💬 |
707 |
Other: use of a postpartum diary and additional blood draws |
- |
- |
- |
- |
288 [1] 288 💬 |
708 |
Other: use of a postpartum diary and additional blood draws. |
- |
- |
- |
- |
288 [1] 288 💬 |
709 |
Other: uspio mri - gadolinium mri |
Gadolinium |
- |
- |
- |
013 [1] 13 💬 |
710 |
Other: usual care |
- |
- |
- |
- |
046 [1] 46 💬 |
711 |
Other: usual care arm exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
712 |
Other: usual drug treatment of parkinson's disease |
- |
- |
- |
- |
006 [1] 6 💬 |
713 |
Other: vasculopathy assessment |
- |
- |
- |
- |
051 [1] 51 💬 |
714 |
Other: vegan diet |
- |
- |
- |
- |
046 [1] 46 💬 |
715 |
Other: vegetable oil |
- |
- |
- |
- |
257 [1] 257 💬 |
716 |
Other: vehicle |
- |
- |
- |
- |
160 [1] 160 💬 |
717 |
Other: vehicle (d5w or saline) |
- |
- |
- |
- |
066 [1] 66 💬 |
718 |
Other: vestibular habituation exercises |
- |
- |
- |
- |
013 [1] 13 💬 |
719 |
Other: vestibular rehabilitation: balance and eye movement exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
720 |
Other: virtual reality group |
- |
- |
- |
- |
013 [1] 13 💬 |
721 |
Other: visual acuity (va) |
- |
- |
- |
- |
090 [2] 90, 301 💬 |
722 |
Other: vital signs |
- |
- |
- |
- |
019 [1] 19 💬 |
723 |
Other: vitamin k |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
013 [1] 13 💬 |
724 |
Other: vitamin k cream |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
013 [1] 13 💬 |
725 |
Other: voluntary cough test |
- |
- |
- |
- |
006 [1] 6 💬 |
726 |
Other: walk distance test |
- |
- |
- |
- |
058 [1] 58 💬 |
727 |
Other: water |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
728 |
Other: water prescription |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
729 |
Other: wheat flour |
Wheat |
[1] D06902 D06902 💬 |
- |
- |
266 [1] 266 💬 |
730 |
Other: withdrawal from alpha1 antitrypsin replacement therapy |
- |
- |
- |
- |
231 [1] 231 💬 |
731 |
Other: withdrawal of dalfampridine-er 10mg |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
732 |
Other: xanthan gum |
Xanthan gum |
[1] D06333 D06333 💬 |
- |
- |
098 [1] 98 💬 |
733 |
Otilimab |
Otilimab |
[1] D11343 D11343 💬 |
CSF2 [1] CSF2 💬 |
Acute myeloid leukemia [16] Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer |
046 [1] 46 💬 |
734 |
Otilimab (gsk3196165) |
Otilimab |
[1] D11343 D11343 💬 |
CSF2 [1] CSF2 💬 |
Acute myeloid leukemia [16] Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer |
046 [1] 46 💬 |
735 |
Otl-101 |
- |
- |
- |
- |
065 [1] 65 💬 |
736 |
Otl-103 |
- |
- |
- |
- |
065 [1] 65 💬 |
737 |
Otl-103 dispersion for infusion |
- |
- |
- |
- |
065 [1] 65 💬 |
738 |
Otl-200 dispersion for infusion |
- |
- |
- |
- |
019 [1] 19 💬 |
739 |
Otl38 |
- |
- |
- |
- |
046 [1] 46 💬 |
740 |
Phase 1: methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
741 |
Pn 200 tablets (500 mg naproxen and 20 mg omeprazole) |
Naproxen |
[5] D00118 D00118, D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [4] ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [2] 46, 271 💬 |
742 |
Po ciprofloxacin |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
743 |
Procedure: other intervention(s) |
- |
- |
- |
- |
070 [1] 70 💬 |
744 |
Response to anakinra associated with methotrexate |
Anakinra |
[3] D00142 D00142, D02115 D02115, D02934 D02934 💬 |
DHFR [4] DHFR, DHFR2, IL1R1, IL1R2 💬 |
Amoebiasis [20] Amoebiasis, Antifolate resistance, Biosynthesis of cofactors, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Metabolic pathways, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
046 [1] 46 💬 |
745 |
Response to infliximab associated with methotrexate |
Infliximab |
[3] D00142 D00142, D02115 D02115, D02598 D02598 💬 |
DHFR [3] DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
746 |
Rifaximin+omeprazole+miralax |
Omeprazole |
[5] D00455 D00455, D01207 D01207, D02554 D02554, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 [1] 96 💬 |
747 |
See d.3.9.3 'other descriptive name' below |
- |
- |
- |
- |
046 [1] 46 💬 |
748 |
Stable weekly dose of methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
749 |
Tacrolimus with methotrexate |
Methotrexate |
[4] D00107 D00107, D00142 D00142, D02115 D02115, D08556 D08556 💬 |
DHFR [7] DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
750 |
Tak-715 and methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
751 |
Tak-783 and methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
752 |
Tasocitinib plus methotrexate |
Methotrexate |
[3] D00142 D00142, D02115 D02115, D09970 D09970 💬 |
DHFR [6] DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [40] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
753 |
Tnf-alpha antagonist and other biotherapy |
- |
- |
- |
- |
046 [1] 46 💬 |
754 |
Tocilizumab + methotrexate(mtx) |
Methotrexate |
[3] D00142 D00142, D02115 D02115, D02596 D02596 💬 |
DHFR [3] DHFR, DHFR2, IL6R 💬 |
Antifolate resistance [17] Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
755 |
Tocilizumab plus methotrexate |
Methotrexate |
[3] D00142 D00142, D02115 D02115, D02596 D02596 💬 |
DHFR [3] DHFR, DHFR2, IL6R 💬 |
Antifolate resistance [17] Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
756 |
Tocilizumab+methotrexate(mtx) |
Methotrexate |
[3] D00142 D00142, D02115 D02115, D02596 D02596 💬 |
DHFR [3] DHFR, DHFR2, IL6R 💬 |
Antifolate resistance [17] Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
757 |
Tofacitinib with methotrexate |
Methotrexate |
[3] D00142 D00142, D02115 D02115, D09970 D09970 💬 |
DHFR [6] DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [40] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
758 |
Tofacitinib without methotrexate |
Methotrexate |
[3] D00142 D00142, D02115 D02115, D09970 D09970 💬 |
DHFR [6] DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [40] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
759 |
Treatment with systemic therapy (methotrexate) |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
162 [1] 162 💬 |
760 |
Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |